PI3K/mTOR inhibitors were a feasible therapeutic approach to sensitize SCLC cells to radiation by promoting G6PD autophagic degradation and aggravating oxidative stress damage, with no apparent side effects. Here, G6PD is linked to small cell lung carcinoma.